We are live on ! Find out more
GCVRZ

Sanofi Contingent Value Rights
GCVRZ

Delisted

GCVRZ was delisted on the 3rd of March, 2020.

Back to rankings

114 hedge funds and large institutions have $12.6M invested in Sanofi Contingent Value Rights in 2015 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 19 increasing their positions, 22 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

3% less funds holding

Funds holding: 117 → 114 (-3)

13% less first-time investments, than exits

New positions opened: 14 | Existing positions closed: 16

14% less repeat investments, than reductions

Existing positions increased: 19 | Existing positions reduced: 22

34% less capital invested

Capital invested by funds: $19.2M → $12.6M (-$6.57M)

Holders
114
Holders Change
-3
Holders Change %
-2.56%
% of All Funds
2.99%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
14
Increased
19
Reduced
22
Closed
16
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
SCM
Stonehill Capital Management
New York
+$1.97M
2
NGA
New Generation Advisors
Massachusetts
+$861K
3
TL
TowerView LLC
New York
+$99.1K
4
EM
Elliott Management
New York
+$93.7K
5
Millennium Management
Millennium Management
New York
+$70.6K

Top Sellers

Rank Fund Capital Flow
1
WA
Whitebox Advisors
Minnesota
-$714K
2
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
-$604K
3
Brown Advisory
Brown Advisory
Maryland
-$271K
4
DAM
Deltec Asset Management
New York
-$138K
5
CL
CSS LLC
Illinois
-$90.5K
Name Holding Trade Value Shares
Change 		Change in
Stake
BCM
26
Basso Capital Management
Connecticut
$42K +$21.2K +150,000 +68%
Goldman Sachs
27
Goldman Sachs
New York
$37K +$2.69K +19,033 +6%
Citadel Advisors
28
Citadel Advisors
Florida
$31K +$14.6K +103,217 +61%
TI
29
Telemetry Investments
New York
$23K -$12K -85,300 -29%
UBS Group
30
UBS Group
Switzerland
$19K +$5.36K +37,965 +28%
YCM
31
Yakira Capital Management
Connecticut
$17K – – –
LCM
32
Lonestar Capital Management
California
$17K +$20.7K +146,879 New
First Eagle Investment Management
33
First Eagle Investment Management
New York
$16K – – –
EEG
34
E.E. Geduld
$14K – – –
PC
35
Permanens Capital
New York
$13K +$16K +112,982 New
ZIG
36
Zuckerman Investment Group
Illinois
$11K -$119 -845 -0.8%
JP Morgan Chase
37
JP Morgan Chase
New York
$11K – – –
PP
38
Paloma Partners
Connecticut
$11K – – –
IRF
39
IBM Retirement Fund
New York
$8K +$9.8K +69,395 New
Wells Fargo
40
Wells Fargo
California
$7K -$1.85K -13,098 -17%
GI
41
GAMCO Investors
Connecticut
$7K -$847 -6,000 -8%
Susquehanna International Group
42
Susquehanna International Group
Pennsylvania
$7K +$8.73K +61,858 New
KAM
43
Kazazian Asset Management
Florida
$6K -$897 -6,352 -11%
OCM
44
Osterweis Capital Management
California
$6K – – –
Commonwealth Equity Services
45
Commonwealth Equity Services
Massachusetts
$5K – – –
Korea Investment Corp
46
Korea Investment Corp
South Korea
$5K – – –
Morgan Stanley
47
Morgan Stanley
New York
$4K -$132 -938 -2%
WHI
48
William Harris Investors
Illinois
$4K -$96 -681 -2%
WC
49
Whitney & Co
New York
$4K -$14 -100 -0.3%
CHAM
50
Clear Harbor Asset Management
Connecticut
$4K – – –
1
2
3 4

GCVRZ Hedge Fund Activity: Q4 2015 in Review

114 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Sanofi Contingent Value Rights (GCVRZ) for Q4 2015, worth a combined $12.6M — down 34% from $19.2M a quarter earlier.

Sellers outnumbered buyers: 16 funds closed out of GCVRZ and 14 opened new positions — a net loss of 2 holders — while 22 trimmed existing stakes and 19 added.

The largest buyer was Stonehill Capital Management, adding an estimated $1.97M. The largest seller was Whitebox Advisors, cutting an estimated $714K.

  • 114 institutional investors held Sanofi Contingent Value Rights (GCVRZ) as of Q4 2015, down from 117 in Q3 2015.
  • Funds reported $12.6M of Sanofi Contingent Value Rights stock for Q4 2015, down 34% quarter-over-quarter.
  • 14 funds opened new Sanofi Contingent Value Rights positions in Q4 2015 and 16 closed out, a net change of -2 holders.
  • The largest Sanofi Contingent Value Rights buyer in Q4 2015 was Stonehill Capital Management, an estimated $1.97M added.
  • The largest Sanofi Contingent Value Rights seller in Q4 2015 was Whitebox Advisors, an estimated $714K sold.

Based on aggregated 13F filings for Q4 2015.